Inhibitor Therapeutics, Inc. (INTI)
Data as of , from SEC Form 4 filings.
See up to 3 months of INTI. The 7-day demo opens the 1M and 3M ranges and puts INTI on your watchlist.
Start 7-day demoLatest INTI insider trades
About Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. files with the SEC under CIK 0001042418 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
INTI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 4 | 200,000 | |
| Bona-fide gift | 1 | 3,200,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
INTI insider transactions (Form 4)
1212 Form 4 filings on record, the earliest from Apr 7, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Black Robe Capital LLC - 10% Owner | Gift | Common Stock | 3,200,000 | $0.00 | - | |
| Ronald E. Osman - Director | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Michelle Yanez - Director | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Samuel P. Sears Jr. - Director | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Francis E. Odonnell Jr. - Officer | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Michael Allen Jerman - Director | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Niraj Vasisht - Director | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Niraj Vasisht - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Michelle Yanez - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Samuel P. Sears Jr. - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Ronald E. Osman - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Michael Allen Jerman - Director | Grant or award | Common Stock | 50,000 | $0.00 | - | |
INTI insider trading FAQ
What is the latest insider trade for INTI?
Inhibitor Therapeutics, Inc. (INTI) had 5 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for INTI runs to 12 Form 4 filings, the earliest from 2025-04-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INTI stock?
No insider purchases of INTI were filed in the last 90 days.
How many insiders are selling INTI stock?
No insider sales of INTI were filed in the last 90 days.
Where can I see INTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INTI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Black Robe Capital LLC view on EDGAR
- - Ronald E. Osman view on EDGAR
- - Michelle Yanez view on EDGAR
- - Samuel P. Sears Jr. view on EDGAR
- - Francis E. Odonnell Jr. view on EDGAR
- - Michael Allen Jerman view on EDGAR
- - Niraj Vasisht view on EDGAR
- - Niraj Vasisht view on EDGAR
- - Michelle Yanez view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INTI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INTI with a 7-day demo
- INTI on your watchlist
- Every INTI Form 4 filing on record
- Up to 3 months of INTI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
